Unlike APP and PSEN mutations, which directly affect Aβ production, TREM2 mutations are suggested to influence AD onset through the clearance of amyloid deposits and neuroinflammatory responses to Aβ aggregates [7,8]. Here, APP is linked to Alzheimer disease.